RNA interference (RNAi) technology has emerged as one of the most promising innovations in molecular biology and biotechnology, with high potential in therapeutic, agricultural, and research ...
As part of the initiative, Oracle Health and M42 will integrate data from the Emirati Genome Programme1 directly into the electronic health record (EHR) ...
Metagenomic assays unlock new avenues in medical treatment by identifying chronic infection causes and elucidating microbiome secrets. This innovative genetic testing, now more affordable, is ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
A sweeping new proposed rule would expand both who must submit biometric data during immigration proceedings and the kinds of biometrics the agency can collect.
A new bioengineering platform enables the large-scale production of human kidney organoids that can be perfused within pig kidneys, maintaining viability and function without immune rejection.
The FDA’s platform technology designation program is intended to provide efficiencies in drug development, manufacturing, and review processes for drug product applications that ... redosable genetic ...
A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined with pig kidneys outside the body and ...
Amgen to present new data from cardiovascular portfolio, including late-breaking results from phase 3 VESALIUS-CV trial of Repatha at AHA scientific sessions: Thousand Oaks, Calif ...
At the core of genetic testing in healthcare lies the ability to read and interpret an individual's DNA. This powerful ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced that new clinical data will be presented in three oral ...